Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.24
-0.01 (-0.80%)
At close: Aug 15, 2025, 3:59 PM
1.26
1.61%
After-hours: Aug 15, 2025, 07:16 PM EDT

Marker Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
349.1K 2.25M 1.93M 1.17M 1.24M 1.06M 257.61K 762.66K 3.5M 6.05M 3.95M 791K 964K 1.24M n/a n/a n/a
Cost of Revenue
n/a 2.58M 3.47M 2.33M 2.58M 2.62M 2.04M 2.38M 971.73K 965.01K 3.59M 838.95K 834.22K 820.18K 805.25K 782.83K 754.37K
Gross Profit
349.1K -1.76M -1.54M -1.17M -1.33M -1.56M -1.79M -1.61M 3.76M 5.09M 2.91M -47.95K 129.78K 421.52K -805K -783K -754K
Operating Income
-4.61M -3.86M -2.4M -2.31M -2.55M -2.94M -3.2M -4.13M -5.05M -3.85M -5.83M -9.28M -9.79M -9.76M -10.02M -10.91M -8.78M
Interest Income
162.49K 73.75K 91.68K 115.39K 156.19K 201.34K 218.09K 35.08K 84.65K 109.41K 99.75K 35.79K 3.12K 969.00 791.00 2.4K 1.54K
Pretax Income
-4.45M -3.79M -2.31M -2.19M -2.39M -2.74M -2.98M -4.1M -4.97M -3.04M -6.92M -9.24M -9.91M -9.76M -12.43M -10.91M -8.78M
Net Income
-4.45M -3.84M -2.31M -2.19M -2.39M -2.8M -2.98M 2.52M -4.88M -4M -6.92M -9.21M -9.91M -9.76M -12.43M -10.91M -8.78M
Selling & General & Admin
1.37M 1.03M 854.68K 1.14M 1.22M 1.38M 1.41M 2.52M 2.52M 1.89M 3.23M 3.52M 3.73M 2.99M 3.24M 3.56M 3.14M
Research & Development
3.13M 5.09M 3.47M 2.33M 2.58M 2.62M 2.04M 2.38M 7.27M 5.27M 3.59M 6.55M 7.03M 8.02M 6.78M 7.35M 5.64M
Other Expenses
453.13K 1.93M -1.93M -1.17M -1.24M -1.06M -258K -763K -1.23M 2.75M n/a -791K -964K -8.02M -2.41M -7.35M n/a
Operating Expenses
4.96M 6.11M 2.4M 3.48M 3.79M 1.38M 1.41M 4.13M 4.31M 6.4M 5.83M 9.28M 9.79M 11.01M 10.02M 10.91M 8.78M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.96M 10.45M 2.4M 3.48M 3.79M 3.99M 3.2M 4.13M 8.55M 9.91M 10.97M 9.28M 9.79M 11.01M 10.02M 10.91M 8.78M
Income Tax Expense
n/a 49.96B n/a n/a n/a 3.67K n/a n/a -84K 138.65K 150.6K -35.79K -3.12K -969 -791 -2.4K -1.54K
Shares Outstanding (Basic)
11.11M 9.1M 8.92M 8.92M 8.9M 8.9M 8.83M 8.8M 8.72M 8.4M 8.36M 8.36M 8.31M 8.17M 8.29M 8.3M 5.65M
Shares Outstanding (Diluted)
11.11M 9.1M 8.92M 8.92M 8.9M 8.9M 8.83M 8.8M 8.72M 8.4M 8.36M 8.36M 8.31M 8.31M 8.31M 8.3M 5.65M
EPS (Basic)
-0.4 -0.43 -0.26 -0.25 -0.27 -0.31 -0.34 0.29 -0.57 -0.48 -0.83 -1.11 -1.19 -1.19 -1.5 -1.3 -1.6
EPS (Diluted)
-0.4 -0.43 -0.26 -0.25 -0.27 -0.31 -0.34 0.29 -0.57 -0.48 -0.83 -1.11 -1.19 -1.17 -1.5 -1.3 -1.6
EBITDA
-4.45M 2.73M -2.4M -2.31M -2.55M -2.94M -3.2M -4.13M -3.49M -2.89M -5.83M -4.69M -8.96M -7.7M -9.22M -10.13M -8.03M
EBIT
-4.45M 2.73M -2.4M -2.31M -2.55M -2.74M -3.2M -4.1M -4.97M -3.86M -6.92M -9.24M -9.79M -8.52M -10.02M -10.91M -8.78M
Depreciation & Amortization
4.16M n/a n/a n/a 2.55M 697.28K 697.28K 818.22K 971.73K 965.01K 819.88K 838.95K 834.22K 820.18K 805.25K 782.83K 754.37K